# DMT210 Topical Gel in the Treatment of Atopic Dermatitis

> **NCT02949960** · PHASE2 · COMPLETED · sponsor: **Dermata Therapeutics** · enrollment: 19 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** DMT210 Topical Gel
- **DRUG:** Vehicle Control

## Key facts

- **NCT ID:** NCT02949960
- **Lead sponsor:** Dermata Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2017-07-14
- **Final completion:** 2017-07-14
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02949960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02949960, "DMT210 Topical Gel in the Treatment of Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02949960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*